Safety/tolerability trial of SDZ ENA 713 in patients with probable Alzheimer's disease
- 1 March 1996
- journal article
- clinical trial
- Published by Elsevier in Life Sciences
- Vol. 58 (15) , 1201-1207
- https://doi.org/10.1016/0024-3205(96)00081-1
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Safety and tolerability of CI-979 in patients with alzheimer's diseaseLife Sciences, 1995
- Adrenomedullin mediates vasodilation via CGRP1 receptorsLife Sciences, 1994
- Chapter 53: Brain selective inhibition of acetylcholinesterase: a novel approach to therapy for Alzheimer's diseasePublished by Elsevier ,1993
- Multiple Dose Pharmacokinetics, Safety, and Tolerance of Velnacrine (HP 029) in Healthy Elderly Subjects: A Potential Therapeutic Agent for Alzheimer's DiseaseThe Journal of Clinical Pharmacology, 1990
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984
- Alzheimer's Disease and Senile Dementia: Loss of Neurons in the Basal ForebrainScience, 1982
- GLUCOSE METABOLISM AND ACETYLCHOLINE SYNTHESIS IN RELATION TO NEURONAL ACTIVITY IN ALZHEIMER'S DISEASEThe Lancet, 1980
- SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASEPublished by Elsevier ,1976
- “Mini-mental state”Journal of Psychiatric Research, 1975
- Cerebral Blood Flow in DementiaArchives of Neurology, 1975